SecBot SecBot
8-K ·Filed Jul 9, 2026

IONS

IONIS PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001140361-26-028154
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a routine reaffirmation with zero new information. Monitor the next quarterly earnings release (Q2 2026) for any updates to revenue and EPS trajectory. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$58.25
T+0 close · Jul 9, 2026 · via day close
Latest settled
−25.32%
T+60 · $43.50
Vs SPY
−27.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 10 $58.25entry
  2. T+1 · 4mo ago −2.93%α −2.15% · $56.54
  3. T+5 · 4mo ago −6.18%α −5.62% · $54.65
  4. T+20 · 3mo ago −2.90%α −5.33% · $56.56
  5. T+60 · 6w ago −25.32%α −27.96% · $43.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ionis Pharmaceuticals filed an 8-K reaffirming its previously announced FY2026 financial guidance from April 29, 2026, with no changes. The filing contains no new financial data, preliminary results, or material updates, only a confirmation of prior guidance.

Key Facts

  • Ionis reaffirms previously announced FY2026 financial guidance unchanged from April 29, 2026 Q1 earnings release
  • No new financial metrics, preliminary results, or guidance revisions disclosed
  • Filing contains only a brief Regulation FD disclosure with forward-looking statements

Financial Impact

No new financial data disclosed; guidance unchanged from prior guidance (amounts not republished in this filing)

Risk Factors

  • No new information reduces near-term volatility; stock may drift with sector
  • Forward-looking statements subject to clinical and regulatory risks in Ionis' pipeline

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (33 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-028154
Document: 0001140361-26-028154-index-headers.html0001140361-26-028154
Document: 0001140361-26-028154-index.html0001140361-26-028154
Document: 0001140361-26-028154.txt0001140361-26-028154

Track record

26 reports on IONS

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +32.25% at T+60 after the Jul 9, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $31.00 to $28.01 Now $28.01 +9.65% ▲ +9.65% +7.95% vs SPY
  2. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $44.90 to $40.15 Now $28.01 −37.62% ▼ −10.58% −9.87% vs SPY
  3. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $42.93 to $43.52 Now $28.01 −34.75% ▲ +1.37% +1.93% vs SPY
  4. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $43.91 to $44.39 Now $28.01 −36.21% ▲ +1.09% +0.39% vs SPY
  5. Oct 21, 202626d ago Institutional Cluster Mixed 3/10 Entry $43.91 to $44.39 Now $28.01 −36.21% ▲ +1.09% +0.39% vs SPY
  6. Sep 23, 20267w ago 8-K Bullish 7/10 Entry $43.93 to $44.65 Now $28.01 −36.24% ▲ +1.64% +2.31% vs SPY
  7. Sep 4, 202610w ago 8-K Bearish 7/10 Entry $56.71 to $47.25 Now $28.01 +50.61% ▲ +16.68% +15.56% vs SPY
  8. Sep 4, 202610w ago 8-K Bullish 7/10 Entry $58.09 to $51.44 Now $28.01 −51.78% ▼ −11.45% −10.24% vs SPY
  9. Jul 31, 202615w ago Insider Buy Neutral 4/10 Entry $54.49 to $56.94 Now $28.01 −48.60% ▲ +4.50% +2.47% vs SPY
  10. Jul 29, 202615w ago 8-K Neutral 5/10 Entry $54.04 to $54.19 Now $28.01 −48.17% ▲ +0.28% −5.25% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 8h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 10, 2026